Solicitation #: N0025919Q0063
"Naval Medical Center San Diego (NMCSD) is responsible for providing the U.S. Navy, other military branches, and their military families with reliable quality health care. In addition to maintaining status as one of the nation’s premier care providers, NMCSD is responsible for preparing for deployable support of operational forces, as well as shaping the future of military medicine through education, training and research."
"The objective of this contract is to obtain supplemental service for infectious disease diagnoses of culture negative infections or diagnosis of infections in patients where biopsy or sampling of the suspected infection is precluded due to instability of the patient or inoperable nidi. To accomplish this, quantitative next-generation sequencing done on cell free, whole plasma for a broad range of pathogens, to include DNA viruses, bacteria, fungi, molds, mycobacteria and protozoa is required. Cell free DNA of pathogens can be found in blood regardless of infection site and source. In general, because of the critical nature of the testing and instability of the patients being tested, results are required in 24-72 hours after receipt into contract laboratory."
Due date: 22 July 2019, 7:00 a.m. PDT